Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $165.56 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Antares Pharma, Inc. | $92.43 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $44.72 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $14.74 | 1 | $0 (2021) |
| COLOPLAST CORP | $13.67 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $165.56 | 10 | Antares Pharma, Inc. ($92.43) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Continence Care | ||||||
| 06/23/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 05/06/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 04/01/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: ONCOLOGY | ||||||
| 03/24/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 02/17/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 01/26/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 01/13/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 405 | 483 | $77,099 | $21,979 |
| 2022 | 10 | 429 | 544 | $84,171 | $24,424 |
| 2021 | 13 | 822 | 942 | $104,375 | $31,824 |
| 2020 | 7 | 779 | 924 | $94,895 | $30,331 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 180 | $32,760 | $9,921 | 30.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 62 | $11,408 | $3,244 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 68 | 77 | $8,470 | $2,776 | 32.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 28 | $9,324 | $2,489 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,984 | $1,622 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $4,824 | $1,364 | 28.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 42 | 53 | $4,028 | $415.48 | 10.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 43 | $301.00 | $146.63 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 204 | $37,128 | $12,126 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 46 | $8,464 | $2,210 | 26.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $7,326 | $2,055 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $7,072 | $2,045 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 22 | $5,896 | $1,829 | 31.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 33 | $3,630 | $1,306 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,395 | $1,294 | 24.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 23 | 28 | $2,828 | $693.33 | 24.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 54 | 78 | $5,928 | $619.69 | 10.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 55 | 72 | $504.00 | $247.07 | 49.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 223 | 253 | $45,104 | $13,542 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 64 | $16,375 | $4,990 | 30.5% |
| 51703 | Insertion of indwelling bladder catheter, complicated | Office | 2021 | 11 | 29 | $8,845 | $3,035 | 34.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 55 | 58 | $6,494 | $2,219 | 34.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $6,420 | $1,712 | 26.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $5,451 | $1,659 | 30.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 145 | 170 | $4,624 | $1,338 | 28.9% |
About Randy Wolfe, RNP
Randy Wolfe, RNP is a Nurse Practitioner healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1811319437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Randy Wolfe, RNP has received a total of $165.56 in payments from pharmaceutical and medical device companies, with $165.56 received in 2021. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($165.56).
As a Medicare-enrolled provider, Wolfe has provided services to 2,435 Medicare beneficiaries, totaling 2,893 services with total Medicare billing of $108,558. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Providence, RI
- Active Since 01/16/2014
- Last Updated 04/03/2014
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1811319437
Products in Payments
- XYOSTED (Drug) $92.43
- XTANDI (Drug) $44.72
- KEYTRUDA (Biological) $14.74
- SpeediCath (Device) $13.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Providence
Mrs. Lea Kelly, Np-C, NP-C
Nurse Practitioner — Payments: $3,925
Samira Ouklilane, Np, NP
Nurse Practitioner — Payments: $2,758
Kathy Vincent, Aprn, Np-Bc, APRN, NP-BC
Nurse Practitioner — Payments: $2,363
Natalie Gibson, Dnp, DNP
Nurse Practitioner — Payments: $2,252
Florette Fils-Aima
Nurse Practitioner — Payments: $1,977
Evelyn Asante, Np, NP
Nurse Practitioner — Payments: $1,803